Systematic review of 32 studies (5 meta-analysed, 143 treprostinil-naïve patients) found parenteral treprostinil was effective and safe in paediatric PAH, with significant results on selected efficacy end-points; no randomised trials were available.
Meta-analysisn = 766
Wacker et al. Parenteral treprostinil in paediatric pulmonary arterial hypertension: a systematic review and meta-analysis